Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Sell
38
NHS Quote, Financials, Valuation and Earnings
Last price:
$7.65
Seasonality move
:
0.6%
Day range:
$7.55 - $7.61
52-week range:
$7.47 - $8.67
Dividend yield:
14.28%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
82.1K
Avg. volume:
155.5K
1-year change:
0.6%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNeuberger Berman High Yield Strategies Fund has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Neuberger Berman High Yield Strategies Fund has an estimated downside of -- from its current price of $7.61.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $7.61.
Fair Value
-
According to the consensus of 0 analysts, Neuberger Berman High Yield Strategies Fund has -- downside to fair value with a price target of -- per share.
NHS vs. S&P 500
-
Over the past 5 trading days, Neuberger Berman High Yield Strategies Fund has underperformed the S&P 500 by -4.06% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Neuberger Berman High Yield Strategies Fund does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Neuberger Berman High Yield Strategies Fund has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Neuberger Berman High Yield Strategies Fund reported revenues of --.
Earnings Growth
-
Neuberger Berman High Yield Strategies Fund has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Neuberger Berman High Yield Strategies Fund reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-26 | 2023-12-26 | 2023-12-26 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2017-04-30 | 2018-04-30 | 2019-04-30 | 2020-04-30 | 2021-04-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $11.7M | $10.5M | $9.4M | $10.9M | $7M | |
| Total Assets | $393.4M | $380.4M | $382.3M | $337.8M | $290.6M | |
| Current Liabilities | $5.4M | $3.7M | $5.6M | $5.7M | $4.7M | |
| Total Liabilities | $130.4M | $130.7M | $131.5M | $135.7M | $104.7M | |
| Total Equity | $263M | $249.7M | $250.8M | $202.1M | $185.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-26 | 2023-12-26 | 2023-12-26 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
NHS
Sector
Market Cap
--
--
Price % of 52-Week High
87.72%
--
Dividend Yield
14.28%
--
Shareholder Yield
--
--
1-Year Price Total Return
0.6%
--
Beta (5-Year)
1.899
--
Dividend yield:
14.28%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$7.63
200-day SMA
Sell
Level
$8.03
Bollinger Bands (100)
Sell
Level
7.83 - 8.33
Chaikin Money Flow
Buy
Level
22.5M
20-day SMA
Sell
Level
$7.76
Relative Strength Index (RSI14)
Sell
Level
37.76
ADX Line
Sell
Level
17.78
Williams %R
Neutral
Level
-70.6522
50-day SMA
Sell
Level
$7.90
MACD (12, 26)
Sell
Level
-0.09
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
8.9M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Neuberger Berman High Yield Strategies Fund is closed-end management investment company. It seeks to achieve its investment objective by investing, under normal market conditions, a majority of its total assets in high yield debt securities of U.S. and foreign issuers.
Stock Forecast FAQ
In the current month, NHS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NHS average analyst price target in the past 3 months is --.
-
Where Will Neuberger Berman High Yield Strategies Fund Stock Be In 1 Year?
According to analysts, the consensus estimate is that Neuberger Berman High Yield Strategies Fund share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Neuberger Berman High Yield Strategies Fund?
Analysts are divided on their view about Neuberger Berman High Yield Strategies Fund share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Neuberger Berman High Yield Strategies Fund is a Sell and believe this share price will rise from its current level to --.
-
What Is Neuberger Berman High Yield Strategies Fund's Price Target?
The price target for Neuberger Berman High Yield Strategies Fund over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NHS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Neuberger Berman High Yield Strategies Fund is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NHS?
You can purchase shares of Neuberger Berman High Yield Strategies Fund via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Neuberger Berman High Yield Strategies Fund shares.
-
What Is The Neuberger Berman High Yield Strategies Fund Share Price Today?
Neuberger Berman High Yield Strategies Fund was last trading at $7.65 per share. This represents the most recent stock quote for Neuberger Berman High Yield Strategies Fund. Yesterday, Neuberger Berman High Yield Strategies Fund closed at $7.61 per share.
-
How To Buy Neuberger Berman High Yield Strategies Fund Stock Online?
In order to purchase Neuberger Berman High Yield Strategies Fund stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 26
Power Solutions International [PSIX] is down 5.45% over the past day.
Buy
65
TSLL alert for Dec 26
Direxion Daily TSLA Bull 2X Shares [TSLL] is down 3.71% over the past day.
Buy
75
SMLR alert for Dec 26
Semler Scientific [SMLR] is down 1.75% over the past day.
